The ESH recommends five major drug classes to treat HT: beta-adrenoceptor antagonists (BAA), calcium channel blockers (CCBs), angiotensin-converting-enzyme (ACE) inhibitors, ARBs and diuretics [4]. The gene discussed is ACE; the disease is hematocrit.